Trade Summary

5 days ago, GORDON CARL L, serving as Dir at BlossomHill Therapeutics, Inc. (BLSM), purchased 625,000 shares at $16.00 per share, for a total transaction value of $10,000,000.00. Following this transaction, GORDON CARL L now holds 2,714,279 shares of BLSM.

This purchase represents a 29.91% increase in GORDON CARL L's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, August 10, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, August 12, 2026 at 4:46 PM ET, 2 days after the trade was made.

BlossomHill Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.